Veru (VERU) Non-Current Debt (2018 - 2020)
Veru (VERU) posted quarterly Non-Current Debt of $2.3 million for Q1 2020, down 14.15% year-over-year from $2.7 million in Q2 2019, and up 21.93% quarter-over-quarter from $1.9 million in Q4 2019.
Veru (VERU) Non-Current Debt (2018 - 2020) Analysis & Trends
Veru (VERU) has reported Non-Current Debt for 3 consecutive years, with $2.3 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Non-Current Debt fell 14.15% year-over-year to $2.3 million; the TTM figure through Mar 2020 stood at $2.3 million (down 14.15% YoY), while the FY2019 annual figure was $2.9 million, up 6.84% from the prior year.
- Non-Current Debt advanced to $2.3 million in Q1 2020 per VERU's latest filing, from $1.9 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $5.8 million in Q1 2018 and bottomed at $517314.0 in Q2 2018.
- Historically, Non-Current Debt has averaged $2.9 million across 3 years, with a median of $2.7 million in 2019.
- On a YoY basis, Non-Current Debt climbed as much as 767.86% in 2019 and fell as far as 53.32% in 2019.
- Veru's Non-Current Debt stood at $3.0 million in 2018, then tumbled by 36.13% to $1.9 million in 2019, then advanced by 21.93% to $2.3 million in 2020.
- Business Quant data shows VERU's Non-Current Debt at $2.3 million in Q1 2020, $1.9 million in Q4 2019, and $2.9 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 2.33 Mn |
| Dec 31, 2019 | 1.91 Mn |
| Sep 30, 2019 | 2.89 Mn |
| Jun 30, 2019 | 4.49 Mn |
| Mar 31, 2019 | 2.72 Mn |
| Dec 31, 2018 | 3.00 Mn |
| Sep 30, 2018 | 2.70 Mn |
| Jun 30, 2018 | 517,314.00 |
| Mar 31, 2018 | 5.82 Mn |